Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
United States Gasoline Fund Lp
UGA
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
No Data
AbCellera Moves ABCL635 Into Phase 2 As Losses Continue
AbCellera Biologics Bets Big on 2026 Trial Catalysts
Earnings Call Summary | AbCellera Biologics(ABCL.US) Q1 2026 Earnings Conference
Evan Seigerman Reiterates Buy on AbCellera, Citing Strong ABCL635 Phase 1 Data and Platform Strength; $7 Price Target Maintained
Truist Financial Maintains AbCellera Biologics(ABCL.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Phreesia (PHR), AbCellera Biologics (ABCL) and PACS Group Inc (PACS)